Company intelligence / Profile preview

Canada Royal Enoch Phytomedicine Ltd.

Vancouver, British Columbia, Canadaenophyto.com ↗

Ownership: Private
Development stage: Phase 1

Overview

The company launched a clinical trial of its ginseng-derived Redsenol-1 Plus Noble Ginsenoside Capsules in January 2023. In March 2025, their product Redsenol-1 Plus was included in the National Cancer Institute's Drug Dictionary, highlighting its potential in oncology and supportive care.

Therapeutic areas: OncologyOther
Modalities: Plant-based natural productsGinsenoside supplements
Industry: Biotech

Drug pipeline

1 asset

Redsenol-1 Plus

Unknown

Beyond the preview

Go deeper on Canada Royal Enoch Phytomedicine Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Canada Royal Enoch Phytomedicine Ltd..

Explore the full profile